Previous close | 0.7300 |
Open | 0.9400 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 65.00 |
Expiry date | 2024-05-17 |
Day's range | 0.4900 - 0.9400 |
Contract range | N/A |
Volume | |
Open interest | 1.96k |
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...
Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.